A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatin
Authors:
- 1 January 1987
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 33 (1) , 67-72
Abstract
Summary We have fitted a first-order multicompartment pharmacokinetic model to plasma platinum concentrations measured in nine ovarian cancer patients who received intravenous infusions of cisplatin for 6 h. The time-course of ultrafilterable plasma platinum was similar in all patients studied, and was fitted by a single compartment within the limits of experimental detection. However, the time-course of protein-bound platinum showed marked differences between patients, the differences being explained by distribution to two peripheral compartments. The wide inter-patient variation observed in protein-bound plasma platinum concentrations supports the view that pharmacokinetic modelling should be carried out separately for each patient, since averaging plasma concentrations would have obscured some individual pharmacokinetic characteristics.Keywords
This publication has 10 references indexed in Scilit:
- Total Body Clearance and Platinum Accumulation in Patients Treated with cis-Dichlorodiammine Platinum (II)Therapeutic Drug Monitoring, 1984
- PHARMACOKINETICS OF FREE AND TOTAL PLATINUM SPECIES AFTER SHORT-TERM INFUSION OF CISPLATIN1984
- Problems and pitfalls in estimating average pharmacokinetic parametersEuropean Journal of Clinical Pharmacology, 1984
- Pharmacokinetic modeling of cisplatin disposition in children and adolescents with cancerCancer Chemotherapy and Pharmacology, 1982
- Pharmacokinetics1982
- Clinical kinetics of intact cisplatin and some related speciesClinical Pharmacology & Therapeutics, 1981
- POTENTIAL EFFECTS OF EDEMA ON THE PHARMACOKINETICS OF PLATINUM IN PATIENTS TREATED WITH CIS-DICHLORODIAMMINE PLATINUM (II)1980
- Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusionCancer Chemotherapy and Pharmacology, 1980
- Acute Phase Reactant Proteins in Cancer1979
- Investigation of the Permeability Factor in Ascites and Edema Using Albumin Tagged With I131Gastroenterology, 1952